PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.\', \'Neuroimmunology Unit, Rabin Medical Center, Petah Tikva, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Israel.\', \'Department of Ophthalmology and Neuro-Ophthalmology Unit, Rabin Medical Center, Petah Tikva, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ene.15028
?:hasPublicationType
?:journal
  • European journal of neurology
is ?:pmid of
?:pmid
?:pmid
  • 34288285
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.65
?:rankingScore_hIndex
  • 109
is ?:relation_isRelatedTo_publication of
?:title
  • Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all